¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fluorescent antibody test"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • catalase test
    īŻ¶ó¾ÆÁ¦°Ë»ç
  • challenge test
    À¯¹ß°Ë»ç
  • caloric test
    ¿Â¼ö´«¶³¸²°Ë»ç
  • chemiluminescence test
    È­Çй߱¤°Ë»ç
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • D-xylose test
    D-ÀÚÀϷοÀ½º°Ë»ç
  • dye exclusion test
    »ö¼Ò¹èÁ¦°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´Þ¼±º°°Ë»ç
  • developing test
    Àü°³½ÃÇè
  • direct agglutination test
    Á÷Á¢ÀÀÁý°Ë»ç
  • direct antiglobulin test
    Á÷Á¢Çױ۷κҸ°°Ë»ç
  • direct Coombs test
    Á÷Á¢ÄñÁî°Ë»ç
  • disc sensitivity test
    ¿ø¹Ý¹Î°¨°Ë»ç
  • discrimination test
    ½Äº°°Ë»ç, ÆÇº°°Ë»ç
  • dot blot test
    Á¡Àû°Ë»ç, ¾ó·èÁ¡°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • challenge test
    À¯¹ß°Ë»ç
  • chelation test
    ų·¹ÀÌÆ®È­°Ë»ç
  • chemiluminescence test
    È­Çй߱¤°Ë»ç
  • chemstrip test
    È­Çжì°Ë»ç
  • chi-square test
    Ä«ÀÌÁ¦°ö°ËÁ¤
  • children apperception test
    ¾Æµ¿Åë°¢°Ë»ç
  • clearance test
    û¼ÒÀ²½ÃÇè
  • clock-drawing test
    ½Ã°è±×¸®±â°Ë»ç
  • closed cup flash test
    ¹ÐÆó½ÄÀÎÈ­Á¡°Ë»ç
  • clot retraction test
    Ç÷º´ÅðÃà°Ë»ç, Çǵ¢À̵ڴç±è°Ë»ç
  • coagulase test
    Ç÷ÀåÀÀ°íÈ¿¼Ò°Ë»ç
  • cold pressure test
    Çѳþйڰ˻ç
  • colony inhibition test
    ¼¼Æ÷±ºÇü¼º¾ïÁ¦°Ë»ç, Áý¶ôÇü¼º¾ïÁ¦°Ë»ç
  • color form sorting test
    »öäÇüÅÂÃ߸®±â°Ë»ç
  • colorimetric caries susceptibility test
    ¿ì½Ä°¨¼ö¼ººñ»ö½ÃÇè
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • heterophil antibody
    ÀÌÁ¾Ä£È­¼º Ç×ü
  • heterophil(e) antibody
    ÀÌÁ¾Ä£È­(¼º)Ç×ü(ì¶ðúöÑûùàõù÷ô÷).
  • heterophil(e) antibody reaction
    ÀÌÁ¾Ä£È­(¼º) Ç×ü¹ÝÀÀ(¡­Úãëë).
  • homocytotropic antibody
    µ¿Á¾¼¼Æ÷ģȭ¼º Ç×ü.
  • homologous antibody
    »óµ¿Ç×ü.
  • hybrid antibody molecule
    ÇÏÀ̺긮µåÇ×üºÐÀÚ
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity, antibody-mediated
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
  • immobilizing antibody
    ¿îµ¿¾ïÁ¦Ç×ü.
  • incomplete antibody
    ºÒ¿ÏÀüÇ×ü.
  • incomplete antibody
    ºÒ¿ÏÀüÇ×ü
  • indirect immunofluorescence antibody
    °£Á¢¸é¿ªÇü±¤Ç×ü
  • inhibiting antibody
    ¾ïÁ¦Ç×ü.
  • instructive theory of antibody production
    Áö·É¼³ (Ç×ü»ý»ê)
  • platelet antibody
    Ç÷¼ÒÆÇÇ×ü(¡­ù÷ô÷).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
  • antiplatelet antibody
    Ç×Ç÷¼ÒÆÇÇ×ü
  • antiprolactin antibody
    Ç×ÇÁ·Î¶ôƾ Ç×ü,Ç×À¯ÁóºÐºñÈ£¸£¸óÇ×ü
  • antismooth muscle antibody
    ÇׯòȰ±ÙÇ×ü(ù÷øÁüÁÐÉù÷ô÷).
  • antisperm antibody
    Ç×Á¤ÀÚÇ×ü
  • antithyroglobulin antibody
    Çׯ¼À̷α۷κҸ°<Ç×°©»ó¼±±Û·ÎºÒ¸°>Ç×ü
  • antithyroid antibody
    Ç×°©»ó¼±Ç×ü
  • atypical antibody
    ÀÌÇü<ºñÁ¤Çü>Ç×ü (¡­ù÷ô÷).
  • autoimmune antibody
    ÀÚ°¡¸é¿ªÇ×ü
  • autoimmune antineutrophil antibody
    ÀÚ±â¸é¿ª¼º Ç×È£Áß±¸Ç×ü(¡­ù÷û¿ñéϹù÷ô÷).
  • autoimmune antineutrophil antibody
    ÀÚ°¡¸é¿ª¼º Ç×È£Áß±¸Ç×ü(¡­ù÷û¿ñéϹù÷ô÷).
  • autoimmune antineutrophil antibody
    ÀÚ±â¸é¿ª¼º Ç×È£Áß±¸Ç×ü(?̴̡̰˴̧̰).
  • autoreactive antibody
    ÀÚ°¡¹ÝÀÀ¼ºÇ×ü
  • bivalent antibody
    À̰¡Ç×ü(ì£Ê¤ù÷ô÷).
  • blocking antibody
    Â÷´ÜÇ×ü(ó´Ó¨ù÷ô÷)
  • blocking antibody =blocker
    Â÷´ÜÇ×ü(¡­ù÷ô÷).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
FE fatty ester; fecal emesis; fetal erythroblastosis; fetal erythrocyte; fluid extract; fluorescent ery...
FF degree of fineness of abrasive particles; fat-free; father factor; fecal frequency; fertility factor...
FIA fistula in ano; fluorescent immunoassay; focal immunoassay; Freund incomplete adjuvant
fl femtoliter; filtered load; flexion, flexible; fluorescent; flow; fluid; flutter; foot lambert
fluor fluorescence; fluorescent; fluorometry; fluoroscopy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 11
ADCC Antibody Dependent Cell Cytotoxicity
ADCC Antibody Dependent Cell-Mediated Cytotoxicity
ADCC Antibody Dependent Cellular Cytotoxicity
ADEPT Antibody Directed Enzyme Prodrug Therapy
ADCC Antibody dependent Cytotoxicity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Cartwright test
    īƮ¶óÀÌÆ® ½ÃÇè
  • catalase test
    īŻ·¹À̽º ½ÃÇè
  • cell culture biocompatibility test
    ¼¼Æ÷ ¹è¾ç »ýü ÀûÇÕ¼º °Ë»ç¹ý
  • Chapmans test
    Â÷ÇÁ¸¸ ½ÃÇè
  • Charlton blanching test
    »þ¸¦Åæ ½ÃÇè
  • checkerboard titration test
    ¹ÙµÏÆÇ½Ä ÃøÁ¤¹ý
  • chelation test
    ų·¹ÀÌÆ®È­ ½ÃÇè
  • Cherry-randall test
    ü¸®-Å©¶õ´Þ ½ÃÇè
  • Chido test
    Chido ½ÃÇè
  • cholesterol esterase : Áö¹æ ºÐÇØ È¿¼ÒÀÇ ÀÏÁ¾. ÄÝ·¹½ºÅ×·ÑÀ» ºÐÇØÇÑ´Ù.

    cholesterol test

    ÄÝ·¹½ºÅ×·Ñ ½ÃÇè
  • Chopras test
    ¼îÇÁ¶ó °Ë»ç
    ¾ÈƼ¸óÀ» »ç¿ëÇÏ´Â Ä®¶ó¾ÆÀÚ¸£ Áø´Ü¹ýÀ¸·Î, ¿À¿øÀÚ ÇÔÀ¯ÇÏ´Â Ç÷ûÀ» ºÎÀ¸¸é Á¢ÃË Æò¸é¿¡ ȥŹÀÌ »ý±ä´Ù.
  • chromatin test
    ¿°»öÁú °Ë»ç
    À¯ÀüÀû ¼ºÀ» °áÁ¤ÇÏ´Â °Ë»ç¹ýÀ¸·Î Á¤»ó ¿©¼º¿¡´Â Á¸ÀçÇϳª Á¤»ó ³²¼º¿¡´Â ¾ø´Â ÇÙ ÁÖº¯ ¼º¿°»öÁúÀÇ Á¸À縦 ü¼¼Æ÷¿¡¼­ °Ë»çÇÑ´Ù. ÀÌ ¿°»öÁúÀÇ Á¸Àç´Â XX¿°»öü ±¸¼ºÀÇ ÁöÇ¥ÀÌ´Ù.
  • chromium-51 release test
    Å©·Î¹Å-51 ¹æÃâ ½ÇÇè
    »ì¾ÆÀÖ´Â ¼¼Æ÷¿¡
  • citrate test
    ±¸¿¬»ê¿° ½ÃÇè
  • clomiphene test
    Ŭ·Î¹ÌÆæ ½ÃÇè
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 11
anterior drawer test <investigation> This test is performed with the patient lying on their back with there knee in 90 degrees of flexion with the foot resting firmly on the table. The examiner grasps the top portion of the shin with both hands, positioning the thumbs on either tibial condyle. Stabilising the foot the examiner places pressure slowly on the proximal tibia by moving the shin toward the examiner. Abnormal looseness and movement forward indicates a significant anterior cruciate ligament injury.
(27 Sep 1997)
antibiotic sensitivity test The in vitro testing of bacterial cultures with antibiotics to determine susceptibility of bacteria to antibiotic therapy.
(05 Mar 2000)
antiglobulin test Haemagglutination test in which coombs' reagent (antiglobulin, or anti-human globulin rabbit immune serum) is added to detect incomplete (non-agglutinating, univalent, blocking) antibodies coating erythrocytes. The direct test is applied to red cells which have been coated with antibody in vivo (e.g., in haemolytic disease of newborn, autoimmune haemolytic anaemia, and transfusion reactions). The indirect test is applied to serum to detect the presence of antibody (e.g., in detection of incompatibility in cross-matching tests, detection and identification of irregular antibodies, and in detection of antibodies not identifiable by other means).
(12 Dec 1998)
antithrombin test A procedure for estimating the inhibitory effect of a defibrinated specimen of plasma on the action of thrombin in converting fibrinogen to fibrin.
(05 Mar 2000)
aptitude test An occupation-oriented intelligence test used to evaluate a person's abilities, talents, and skills; particularly valuable in vocational counseling.
(05 Mar 2000)
Apt test A test for identifying foetal blood by the addition of sodium hydroxide and water to a specimen.
(05 Mar 2000)
Aschheim-Zondek test An obsolete test for pregnancy; repeated injections of small quantities of urine voided during the first months of pregnancy produce in infantile mice, within 100 hours, minute intrafollicular ovarian haemorrhages, and the development of lutein cells.
Synonym: A.-Z. Test, Zondek-Aschheim test.
(05 Mar 2000)
Ascoli's test A precipitin test for anthrax using a tissue extract and anthrax antiserum.
(05 Mar 2000)
ascorbate-cyanide test A test for glucose-6-phosphate-deficient red blood cells; blood is incubated with sodium cyanide and ascorbate; the hydrogen peroxide generated is free to oxidise haemoglobin to methemoglobin, since cyanide inhibits catalase; a brown colour is produced more rapidly in glucose 6-phosphate-deficient cells.
(05 Mar 2000)
aspergillus antigen skin test <investigation> An antigen, prepared from aspergillus, is injected into the skin. In 48 to 72 hours the site is read as positive or negative. A positive skin test (inflammation at the test site) indicates prior exposure to aspergillus and therefore a risk for developing aspergillosis.
(27 Sep 1997)
association test A word (stimulus word) is spoken to the subject, who is to reply immediately with another word (reaction word) suggested by the first; used as a diagnostic aid in psychiatry and psychology, clues being given by the length of time (association time) between the stimulus and reaction words, and also by the nature of the reaction words.
(05 Mar 2000)
Astwood's test A test for the assay of oestrogenic substances; immature female rats (25 to 49 g) are injected subcutaneously with the hormone and killed after 6 hours, when the increase in uterine weight (due largely to imbibation of water) is taken as the criterion of oestrogenic activity.
Synonym: Astwood's test.
(05 Mar 2000)
atropine test If an injection of atropine relieves bradycardia, the condition is due to action of the vagus; if it does not, the condition may be due to an affection of the heart itself.
Synonym: atropine test.
(05 Mar 2000)
augmented histamine test A test for maximal production of gastric acidity or anacidity; after preliminary administration of an antihistamine, histamine acid phosphate is injected subcutaneously in a dose of 0.04 mg/kg of body weight, followed by analysis of gastric contents.
Synonym: augmented histamine test.
(05 Mar 2000)
aussage test A test of ability to reproduce correctly something that has been seen for a brief interval.
Origin: Ger. Aussage, a declaration
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 11
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 11
ÅëÇÕ°Ë»ö ¿Ï·á